New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?

Eur Urol. 2007 Oct;52(4):945-7. doi: 10.1016/j.eururo.2007.03.029. Epub 2007 Mar 15.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Diphosphonates / therapeutic use
  • Docetaxel
  • Drug Resistance, Neoplasm*
  • Humans
  • Imidazoles / therapeutic use
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Taxoids / therapeutic use
  • Vinblastine / analogs & derivatives
  • Vinblastine / therapeutic use
  • Vinorelbine
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Imidazoles
  • Taxoids
  • Docetaxel
  • Vinblastine
  • Zoledronic Acid
  • Vinorelbine